Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Harsco Corp. (Symbol: HSC), where a total volume of 3,818 contracts has been traded thus far today, a contract volume which is representative of approximately 381,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 126.4% of HSC's average daily trading volume over the past month, of 302,160 shares. Particularly high volume was seen for the $10 strike put option expiring April 14, 2022, with 3,403 contracts trading so far today, representing approximately 340,300 underlying shares of HSC. Below is a chart showing HSC's trailing twelve month trading history, with the $10 strike highlighted in orange:
C4 Therapeutics Inc (Symbol: CCCC) saw options trading volume of 6,336 contracts, representing approximately 633,600 underlying shares or approximately 125.2% of CCCC's average daily trading volume over the past month, of 505,970 shares. Particularly high volume was seen for the $22.50 strike call option expiring April 14, 2022, with 2,305 contracts trading so far today, representing approximately 230,500 underlying shares of CCCC. Below is a chart showing CCCC's trailing twelve month trading history, with the $22.50 strike highlighted in orange:
And Cutera Inc (Symbol: CUTR) saw options trading volume of 2,088 contracts, representing approximately 208,800 underlying shares or approximately 120.9% of CUTR's average daily trading volume over the past month, of 172,645 shares. Especially high volume was seen for the $30 strike put option expiring September 16, 2022, with 1,000 contracts trading so far today, representing approximately 100,000 underlying shares of CUTR. Below is a chart showing CUTR's trailing twelve month trading history, with the $30 strike highlighted in orange:
For the various different available expirations for HSC options, CCCC options, or CUTR options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
